vs
Ardmore Shipping Corp（ASC）与帕可Bio（PACB）财务数据对比。点击上方公司名可切换其他公司
Ardmore Shipping Corp的季度营收约是帕可Bio的1.8倍（$81.2M vs $44.6M），Ardmore Shipping Corp净利率更高（15.7% vs -90.4%，领先106.2%），帕可Bio同比增速更快（13.8% vs -15.5%），过去两年帕可Bio的营收复合增速更高（7.3% vs -6.0%）
阿德莫尔航运是一家全球化海上运输企业，持有并运营中型成品油轮与化学品运输船队，可为全球能源、化工及贸易领域客户提供石油产品、特种化学品及其他散装液态货物的海运服务。
太平洋生物科学（加利福尼亚）公司是2004年成立的美国生物技术企业，专注于研发生产基因测序相关设备，还可实现新型实时生物观测。公司拥有两大核心测序平台：基于零模波导特性的单分子实时测序平台（SMRT），以及采用天然核苷酸、无损伤掺入完成DNA结合与延伸的结合测序技术（SBB）平台。
ASC vs PACB — 直观对比
营收规模更大
ASC
是对方的1.8倍
$44.6M
营收增速更快
PACB
高出29.3%
-15.5%
净利率更高
ASC
高出106.2%
-90.4%
两年增速更快
PACB
近两年复合增速
-6.0%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $81.2M | $44.6M |
| 净利润 | $12.8M | $-40.4M |
| 毛利率 | — | 37.1% |
| 营业利润率 | 16.1% | -92.3% |
| 净利率 | 15.7% | -90.4% |
| 营收同比 | -15.5% | 13.8% |
| 净利润同比 | -47.0% | -1802.7% |
| 每股收益（稀释后） | $0.30 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASCPACB
| Q4 25 | — | $44.6M | ||
| Q3 25 | $81.2M | $38.4M | ||
| Q2 25 | $72.0M | $39.8M | ||
| Q1 25 | $74.0M | $37.2M | ||
| Q4 24 | — | $39.2M | ||
| Q3 24 | $96.1M | $40.0M | ||
| Q2 24 | $121.3M | $36.0M | ||
| Q1 24 | $106.3M | $38.8M |
净利润ASCPACB
| Q4 25 | — | $-40.4M | ||
| Q3 25 | $12.8M | $-38.0M | ||
| Q2 25 | $9.6M | $-41.9M | ||
| Q1 25 | $6.3M | $-426.1M | ||
| Q4 24 | — | $2.4M | ||
| Q3 24 | $24.1M | $-60.7M | ||
| Q2 24 | $62.7M | $-173.3M | ||
| Q1 24 | $39.2M | $-78.2M |
毛利率ASCPACB
| Q4 25 | — | 37.1% | ||
| Q3 25 | — | 41.4% | ||
| Q2 25 | — | 36.9% | ||
| Q1 25 | — | -3.7% | ||
| Q4 24 | — | 25.6% | ||
| Q3 24 | — | 25.0% | ||
| Q2 24 | — | 16.5% | ||
| Q1 24 | — | 29.1% |
营业利润率ASCPACB
| Q4 25 | — | -92.3% | ||
| Q3 25 | 16.1% | -101.1% | ||
| Q2 25 | 13.5% | -112.8% | ||
| Q1 25 | 8.6% | -1154.5% | ||
| Q4 24 | — | -390.1% | ||
| Q3 24 | 25.4% | -160.3% | ||
| Q2 24 | 51.3% | -488.3% | ||
| Q1 24 | 37.2% | -209.6% |
净利率ASCPACB
| Q4 25 | — | -90.4% | ||
| Q3 25 | 15.7% | -98.9% | ||
| Q2 25 | 13.3% | -105.4% | ||
| Q1 25 | 8.5% | -1146.8% | ||
| Q4 24 | — | 6.0% | ||
| Q3 24 | 25.1% | -151.9% | ||
| Q2 24 | 51.7% | -481.3% | ||
| Q1 24 | 36.9% | -201.4% |
每股收益（稀释后）ASCPACB
| Q4 25 | — | $-0.11 | ||
| Q3 25 | $0.30 | $-0.13 | ||
| Q2 25 | $0.22 | $-0.14 | ||
| Q1 25 | $0.14 | $-1.44 | ||
| Q4 24 | — | $-0.44 | ||
| Q3 24 | $0.55 | $-0.22 | ||
| Q2 24 | $1.47 | $-0.64 | ||
| Q1 24 | $0.92 | $-0.29 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $279.5M |
| 总债务越低越好 | $116.1M | — |
| 股东权益账面价值 | $628.2M | $5.3M |
| 总资产 | $799.8M | $784.1M |
| 负债/权益比越低杠杆越低 | 0.18× | — |
8季度趋势，按日历期对齐
现金及短期投资ASCPACB
| Q4 25 | — | $279.5M | ||
| Q3 25 | — | $298.7M | ||
| Q2 25 | — | $314.7M | ||
| Q1 25 | — | $343.1M | ||
| Q4 24 | — | $389.9M | ||
| Q3 24 | — | $471.1M | ||
| Q2 24 | — | $509.8M | ||
| Q1 24 | — | $561.9M |
总债务ASCPACB
| Q4 25 | — | — | ||
| Q3 25 | $116.1M | — | ||
| Q2 25 | $25.0M | — | ||
| Q1 25 | $20.5M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $22.5M | — | ||
| Q2 24 | $44.2M | — | ||
| Q1 24 | $23.1M | — |
股东权益ASCPACB
| Q4 25 | — | $5.3M | ||
| Q3 25 | $628.2M | $36.1M | ||
| Q2 25 | $618.3M | $61.5M | ||
| Q1 25 | $610.7M | $91.6M | ||
| Q4 24 | — | $506.6M | ||
| Q3 24 | $627.0M | $453.1M | ||
| Q2 24 | $617.7M | $492.7M | ||
| Q1 24 | $567.9M | $649.0M |
总资产ASCPACB
| Q4 25 | — | $784.1M | ||
| Q3 25 | $799.8M | $803.2M | ||
| Q2 25 | $703.8M | $825.5M | ||
| Q1 25 | $690.4M | $860.8M | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | $722.8M | $1.5B | ||
| Q2 24 | $742.0M | $1.5B | ||
| Q1 24 | $704.1M | $1.7B |
负债/权益比ASCPACB
| Q4 25 | — | — | ||
| Q3 25 | 0.18× | — | ||
| Q2 25 | 0.04× | — | ||
| Q1 25 | 0.03× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.04× | — | ||
| Q2 24 | 0.07× | — | ||
| Q1 24 | 0.04× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $17.9M | $-19.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-19.9M |
| 自由现金流率自由现金流/营收 | — | -44.6% |
| 资本支出强度资本支出/营收 | — | 1.9% |
| 现金转化率经营现金流/净利润 | 1.40× | — |
| 过去12个月自由现金流最近4个季度 | — | $-114.1M |
8季度趋势，按日历期对齐
经营现金流ASCPACB
| Q4 25 | — | $-19.1M | ||
| Q3 25 | $17.9M | $-18.7M | ||
| Q2 25 | $11.2M | $-29.4M | ||
| Q1 25 | $26.3M | $-44.1M | ||
| Q4 24 | — | $-30.6M | ||
| Q3 24 | $39.9M | $-45.5M | ||
| Q2 24 | $48.4M | $-54.3M | ||
| Q1 24 | $49.2M | $-75.7M |
自由现金流ASCPACB
| Q4 25 | — | $-19.9M | ||
| Q3 25 | — | $-18.8M | ||
| Q2 25 | — | $-29.9M | ||
| Q1 25 | — | $-45.4M | ||
| Q4 24 | — | $-32.3M | ||
| Q3 24 | — | $-46.3M | ||
| Q2 24 | — | $-55.7M | ||
| Q1 24 | — | $-79.6M |
自由现金流率ASCPACB
| Q4 25 | — | -44.6% | ||
| Q3 25 | — | -48.9% | ||
| Q2 25 | — | -75.3% | ||
| Q1 25 | — | -122.3% | ||
| Q4 24 | — | -82.3% | ||
| Q3 24 | — | -115.7% | ||
| Q2 24 | — | -154.8% | ||
| Q1 24 | — | -205.0% |
资本支出强度ASCPACB
| Q4 25 | — | 1.9% | ||
| Q3 25 | — | 0.2% | ||
| Q2 25 | — | 1.4% | ||
| Q1 25 | — | 3.7% | ||
| Q4 24 | — | 4.1% | ||
| Q3 24 | — | 2.0% | ||
| Q2 24 | — | 4.1% | ||
| Q1 24 | — | 10.0% |
现金转化率ASCPACB
| Q4 25 | — | — | ||
| Q3 25 | 1.40× | — | ||
| Q2 25 | 1.17× | — | ||
| Q1 25 | 4.20× | — | ||
| Q4 24 | — | -12.93× | ||
| Q3 24 | 1.65× | — | ||
| Q2 24 | 0.77× | — | ||
| Q1 24 | 1.25× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASC
暂无分部数据
PACB
| Products | $39.0M | 87% |
| Service And Other | $5.7M | 13% |
